Cancer Profiling Market

Cancer Profiling Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

141

Base Year:

2022

Apr - 2023

Format:

Report Code:

VMR-2101

Segments Covered

By Technology Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Other Technologies
By Cancer Type Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancer
By Biomarker Type Genomic Biomarker, Protein Biomarker, Other Biomarker
By Application Research Application, Clinical Application
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 9.4 Billion
Revenue 2030:	USD 19.28 Billion
Revenue CAGR (2023 - 2030):	10.8%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Cancer Profiling Market Segment Analysis

Cancer Profiling Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Immunoassays
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Mass Spectrometry
- In-Situ Hybridization
- Microarrays
- Other Technologies
Cancer Profiling Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma Cancer
- Other Cancer
Cancer Profiling Biomarker Type Outlook (Revenue, USD Million, 2018 - 2030)
- Genomic Biomarker
- Protein Biomarker
- Other Biomarker
Cancer Profiling Application Outlook (Revenue, USD Million, 2018 - 2030)
- Research Application
- Clinical Application
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
  - North America Cancer Profiling Market, by Technology
    - Immunoassays
    - Next-Generation Sequencing
    - Polymerase Chain Reaction
    - Mass Spectrometry
    - In-Situ Hybridization
    - Microarrays
    - Other Technologies
  - North America Cancer Profiling Market, by Cancer Type
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Melanoma Cancer
    - Other Cancer
  - North America Cancer Profiling Market, by Biomarker Type
    - Genomic Biomarker
    - Protein Biomarker
    - Other Biomarker
  - North America Cancer Profiling Market, by Application
    - Research Application
    - Clinical Application
  - U.S.
    - U.S. Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - U.S. Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - U.S. Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - U.S. Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Canada
    - Canada Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Canada Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Canada Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Canada Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Mexico
    - Mexico Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Mexico Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Mexico Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Mexico Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
- Europe
  - Europe Cancer Profiling Market, by Technology
    - Immunoassays
    - Next-Generation Sequencing
    - Polymerase Chain Reaction
    - Mass Spectrometry
    - In-Situ Hybridization
    - Microarrays
    - Other Technologies
  - Europe Cancer Profiling Market, by Cancer Type
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Melanoma Cancer
    - Other Cancer
  - Europe Cancer Profiling Market, by Biomarker Type
    - Genomic Biomarker
    - Protein Biomarker
    - Other Biomarker
  - Europe Cancer Profiling Market, by Application
    - Research Application
    - Clinical Application
  - U. K.
    - U.K. Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - U.K. Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - U.K. Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - U.K. Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - France
    - France Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - France Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - France Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - France Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Germany
    - Germany Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Germany Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Germany Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Germany Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Italy
    - Italy Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Italy Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Italy Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Italy Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Spain
    - Spain Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Spain Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Spain Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Spain Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Rest of Europe
    - Rest of Europe Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Rest of Europe Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Rest of Europe Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Rest of Europe Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
- Asia Pacific
  - Asia Pacific Cancer Profiling Market, by Technology
    - Immunoassays
    - Next-Generation Sequencing
    - Polymerase Chain Reaction
    - Mass Spectrometry
    - In-Situ Hybridization
    - Microarrays
    - Other Technologies
  - Asia Pacific Cancer Profiling Market, by Cancer Type
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Melanoma Cancer
    - Other Cancer
  - Asia Pacific Cancer Profiling Market, by Biomarker Type
    - Genomic Biomarker
    - Protein Biomarker
    - Other Biomarker
  - Asia Pacific Cancer Profiling Market, by Application
    - Research Application
    - Clinical Application
  - China
    - China Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - China Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - China Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - China Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Japan
    - Japan Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Japan Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Japan Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Japan Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Germany
    - Germany Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Germany Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Germany Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Germany Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - India
    - India Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - India Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - India Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - India Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - South Korea
    - South Korea Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - South Korea Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - South Korea Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - South Korea Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - South East Asia
    - South East Asia Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - South East Asia Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - South East Asia Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - South East Asia Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Rest of Asia Pacific
    - Rest of Asia Pacific Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Rest of Asia Pacific Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Rest of Asia Pacific Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Rest of Asia Pacific Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
- Latin America
  - Latin America Cancer Profiling Market, by Technology
    - Immunoassays
    - Next-Generation Sequencing
    - Polymerase Chain Reaction
    - Mass Spectrometry
    - In-Situ Hybridization
    - Microarrays
    - Other Technologies
  - Latin America Cancer Profiling Market, by Cancer Type
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Melanoma Cancer
    - Other Cancer
  - Latin America Cancer Profiling Market, by Biomarker Type
    - Genomic Biomarker
    - Protein Biomarker
    - Other Biomarker
  - Latin America Cancer Profiling Market, by Application
    - Research Application
    - Clinical Application
  - Brazil
    - Brazil Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Brazil Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Brazil Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Brazil Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Argentina
    - Argentina Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Argentina Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Argentina Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Argentina Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Rest of Latin America
    - Rest of Latin America Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Rest of Latin America Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Rest of Latin America Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Rest of Latin America Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
- Middle East & Africa
  - Middle East & Africa Cancer Profiling Market, by Technology
    - Immunoassays
    - Next-Generation Sequencing
    - Polymerase Chain Reaction
    - Mass Spectrometry
    - In-Situ Hybridization
    - Microarrays
    - Other Technologies
  - Middle East & Africa Cancer Profiling Market, by Cancer Type
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Melanoma Cancer
    - Other Cancer
  - Middle East & Africa Cancer Profiling Market, by Biomarker Type
    - Genomic Biomarker
    - Protein Biomarker
    - Other Biomarker
  - Middle East & Africa Cancer Profiling Market, by Application
    - Research Application
    - Clinical Application
  - GCC Countries
    - GCC Countries Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - GCC Countries Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - GCC Countries Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - GCC Countries Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - South Africa
    - South Africa Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - South Africa Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - South Africa Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - South Africa Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application
  - Rest of Middle East & Africa
    - Rest of Middle East & Africa Cancer Profiling Market, by Technology
      - Immunoassays
      - Next-Generation Sequencing
      - Polymerase Chain Reaction
      - Mass Spectrometry
      - In-Situ Hybridization
      - Microarrays
      - Other Technologies
    - Rest of Middle East & Africa Cancer Profiling Market, by Cancer Type
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Melanoma Cancer
      - Other Cancer
    - Rest of Middle East & Africa Cancer Profiling Market, by Biomarker Type
      - Genomic Biomarker
      - Protein Biomarker
      - Other Biomarker
    - Rest of Middle East & Africa Cancer Profiling Market, by Application
      - Research Application
      - Clinical Application

Vantage Market Research | 27-Apr-2023

Cancer Profiling Market to Reach Valuation of USD 19.28 Billion by 2030 – Growth in The Microbiome Effects and The Rising Prevalence of Cancer Cases Drive the Market

FAQ

Frequently Asked Question

What is the global demand for Cancer Profiling in terms of revenue?

The global Cancer Profiling valued at USD 9.4 Billion in 2022 and is expected to reach USD 19.28 Billion in 2030 growing at a CAGR of 10.8%.

Which are the prominent players in the market?

The prominent players in the market are Illumina Inc. (U.S.), QIAGEN (Germany), NeoGenomics Laboratories Inc. (U.S.), HTG Molecular Diagnostics Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies Inc. (U.S.), Sysmex Corporation (Japan), Ribomed Biotechnologies, Inc. (U.S.), Guardant Health, Inc. (U.S.), Foundation Medicine (U.S.) Roche Diagnostics (Switzerland), (U.S.), GenScript Biotech Corporation (China), Tempus Labs (U.S.), Boreal Genomics Inc (Canada), Perthera (U.S.), Agendia (U.S.), Omniseq (U.S.) Histogene X (Belgium).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 10.8% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Cancer Profiling include
- Rising incidence of cancer

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Cancer Profiling in 2022.

Cancer Profiling Market

Cancer Profiling Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

Cancer Profiling Market Segment Analysis

FAQ

Frequently Asked Question

What is the global demand for Cancer Profiling in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Cancer Profiling Market

Cancer Profiling Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

Cancer Profiling Market Segment Analysis

FAQ

Frequently Asked Question

What is the global demand for Cancer Profiling in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Cancer Profiling Market

Vantage Point Interactive Dashboard